NCT06359353 - Effect of Pitavastatin on Bone | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 8, 2019

Primary Completion Date

February 10, 2022

Study Completion Date

December 19, 2023

Conditions

Osteoporosis, OsteopeniaHypercholesterolemiaMenopausal Osteoporosis

Interventions

DRUG

Pitavastatin

"Pitavastatin 2 mg or 4 mg once daily~\* The dosage is determined based on cholesterol levels and the physician's decision."

Trial Locations (1)

Seoul National University Bundang Hospital, Seongnam-si